Gupta Bhavna, Jain Gaurav, Chandrakar Saurabh, Gupta Nidhi, Agarwal Ankit
Department of Anaesthesia and Critical Care, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
Indian J Crit Care Med. 2021 Aug;25(8):866-871. doi: 10.5005/jp-journals-10071-23917.
The alveolar-arterial oxygen (A-a) gradient measures the difference between the oxygen concentration in alveoli and the arterial system, which has considerable clinical utility. It was a retrospective, observational cohort study involving the analysis of patients diagnosed with acute COVID pneumonia and required noninvasive mechanical ventilation (NIV) over a period of 3 months. The primary objective was to investigate the utility of the A-a gradient (pre-NIV) as a predictor of 28-day mortality in COVID pneumonia. The secondary objective included the utility of other arterial blood gas (ABG) parameters (pre-NIV) as a predictor of 28-day mortality. The outcome was also compared between survivors and nonsurvivors. The outcome variables were analyzed by receiver-operating characteristic (ROC) curve, Youden index, and regression analysis. The optimal criterion for A-a gradient to predict 28-day mortality was calculated as ≤430.43 at a Youden index of 0.5029, with the highest area under the curve (AUC) of 0.755 ( <0.0001). On regression analysis, the odds ratio for the A-a gradient was 0.99. A significant difference was observed in ABG predictors, including PaO, PaCO, A-a gradient, AO, and arterial-alveolar (a-A) (%) among nonsurvivors vs survivors (-value <0.001). The vasopressor requirement, need for renal replacement therapy, total parenteral requirement, and blood transfusion were higher among nonsurvivors; however, a significant difference was achieved with the vasopressor need ( <0.001). This study demonstrated that the A-a gradient is a significant predictor of mortality in patients initiated on NIV for worsening respiratory distress in COVID pneumonia. All other ABG parameters also showed a significant AUC for predicting 28-day mortality, although with variable sensitivity and specificity. COVID-19 pneumonia shows an initial presentation with type 1 respiratory failure with increased A-a gradient, while a subsequent impending type 2 respiratory failure requires invasive ventilation. A significant difference was observed in ABG predictors, including PaO, PaCO, A-a gradient, AO, and a-A (%) among nonsurvivors vs survivors. (-value <0.001). The vasopressor requirement, need for renal replacement therapy, total parenteral requirement, and blood transfusion need were higher among nonsurvivors than survivors; however, a significant difference was achieved with the vasopressor need ( <0.001). Gupta B, Jain G, Chandrakar S, Gupta N, Agarwal A. Arterial Blood Gas as a Predictor of Mortality in COVID Pneumonia Patients Initiated on Noninvasive Mechanical Ventilation: A Retrospective Analysis. Indian J Crit Care Med 2021;25(8):866-871.
肺泡-动脉血氧(A-a)梯度用于测量肺泡与动脉系统中氧浓度的差异,具有重要的临床应用价值。这是一项回顾性观察队列研究,对在3个月内被诊断为急性新冠肺炎且需要无创机械通气(NIV)的患者进行分析。主要目的是研究A-a梯度(NIV前)作为新冠肺炎患者28天死亡率预测指标的效用。次要目的包括其他动脉血气(ABG)参数(NIV前)作为28天死亡率预测指标的效用。还对幸存者和非幸存者的结果进行了比较。通过受试者工作特征(ROC)曲线、约登指数和回归分析对结果变量进行分析。预测28天死亡率的A-a梯度最佳标准计算为≤430.43,约登指数为0.5029,曲线下面积(AUC)最高为0.755(<0.0001)。回归分析显示,A-a梯度的比值比为0.99。在非幸存者与幸存者之间,ABG预测指标(包括PaO、PaCO、A-a梯度、AO和动脉-肺泡[a-A]%)存在显著差异(P值<0.001)。非幸存者的血管升压药需求量、肾脏替代治疗需求、全胃肠外营养需求量和输血需求量更高;然而,血管升压药需求存在显著差异(P<0.001)。本研究表明,对于因新冠肺炎呼吸窘迫加重而开始接受NIV治疗的患者,A-a梯度是死亡率的重要预测指标。所有其他ABG参数在预测28天死亡率时也显示出显著的AUC,尽管敏感性和特异性各不相同。新冠肺炎肺炎最初表现为1型呼吸衰竭,A-a梯度升高,而随后即将发生的2型呼吸衰竭则需要有创通气。在非幸存者与幸存者之间,ABG预测指标(包括PaO、PaCO、A-a梯度、AO和a-A%)存在显著差异(P值<0.001)。非幸存者的血管升压药需求量、肾脏替代治疗需求、全胃肠外营养需求量和输血需求均高于幸存者;然而,血管升压药需求存在显著差异(P<0.001)。古普塔B、贾恩G、钱德拉卡尔S、古普塔N、阿加瓦尔A。动脉血气作为新冠肺炎肺炎患者无创机械通气死亡率预测指标的回顾性分析。《印度重症监护医学杂志》2021年;25(8):866 - 871。